In:
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 48, No. 8 ( 2004-08), p. 3107-3111
Kurzfassung:
The activities of ravuconazole and four other antifungal agents were tested against a collection of 1,796 clinical yeast isolates, including fluconazole-susceptible and -resistant strains. Ravuconazole was active against the majority of fluconazole-resistant isolates; but for 102 of 562 (18%) resistant isolates, mainly Candida tropicalis , Candida glabrata , and Cryptococcus neoformans , ravuconazole MICs were ≥1 μg/ml.
Materialart:
Online-Ressource
ISSN:
0066-4804
,
1098-6596
DOI:
10.1128/AAC.48.8.3107-3111.2004
Sprache:
Englisch
Verlag:
American Society for Microbiology
Publikationsdatum:
2004
ZDB Id:
1496156-8
SSG:
12
SSG:
15,3